Philip Cola, professor of design and innovation at Weatherhead School of Management, recently penned an article published in the Journal of Clinical Psychopharmacology. Cola also holds a secondary appointment at the School of Medicine.
Cola collaborated with colleagues from Vanderbilt University and Northwestern University to write the article, titled “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia.”
The paper is based on research from a 15-year outcome study of using an atypical antipsychotic medication to treat what was once thought to be treatment-resistant schizophrenia.